Showing results (161-170 of 281) with videos related to
Sort By:
Pageof 29
European Journal of Pharmacology|September 16, 2000
The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptorP Gouldson, P Legoux, C Carillon, et al.Molecular & General Genetics : MGG|January 15, 1996
Cloning and characterization of the eapB and eapC genes of Cryphonectria parasitica encoding two new acid proteinases, and disruption of eapCP Jara, S Gilbert, P Delmas, et al.Molecular Immunology|November 1, 1991
Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodiesJ Wijdenes, C Clement, B Klein, et al.Cancer Investigation|January 1, 1994
3H-NECA binding to polymorphonuclear membrane: effect of sera from patients with Hodgkin's diseaseR Polidori, P Tacchi, A Azzará, et al.Brain Research. Molecular Brain Research|July 24, 1998
Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brainN Walker, I Lepee-Lorgeoux, J Fournier, et al.European Journal of Pharmacology|December 14, 1999
Contrasting roles of leu(356) in the human CCK(1) receptor for antagonist SR 27897 and agonist SR 146131 bindingP Gouldson, P Legoux, C Carillon, et al.Life Sciences|August 26, 1999
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528D Shire, B Calandra, M Bouaboula, et al.European Journal of Pharmacology|February 26, 2000
Essential role of extracellular charged residues of the human CCK(1) receptor for interactions with SR 146131, SR 27897 and CCK-8SP Gouldson, P Legoux, C Carillon, et al.Biochimie|April 11, 2001
Degradation of cellular and viral Fos proteinsC Acquaviva, P Ferrara, G Bossis, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell lineL Rimsky, H Wakasugi, P Ferrara, et al.Pageof 29